Subcutaneous (under the skin) with an insulin syringe
Although most irAEs are identified during pre-clinical development, the spectrum, timing and outcomes were only recently investigated through real-world, large-scale pharmacovigilance analyses like the spontaneous reporting systems that looked at the real-time monitoring of these drugs safety profiles [16]
[14] Doctors usually recommend intramuscular injections, which is what we're describing
The rationale for injectable administration stems from the limitations of topical delivery
Key determinants of success include nanoscale size optimization, surface charge modulation, and ligand-mediated targeting, which exploit endogenous transport pathways at the bloodbrain barrier
The excessive production of ROS during ARDS creates an environment conducive to ferroptotic cell death